World's First

3-lead 14 day continuous ECG and remote event device.

The Zensor™ device enables early detection of Atrial Fibrillation and other common cardiac arrhythmias in your patients.

Zensor™ device

Zensor™ is a 3-lead intelligent, wearable, non-invasive, 14 day continuous ECG and remote event device. This small yet powerful system enables the transmission of comprehensive ECG data to allow you to diagnose patient arrhythmias including Atrial Fibrillation. Cleared for use by the US FDA and CE marked, the Zensor™ device is a wi-fi enabled patient monitor that captures the electrical rhythm and the rate of your patient’s heart rate for up to 14 days.

Key

Features

  • 3 lead wi-fi enabled ECG monitor
  • Up to 14 day continuous beat by beat data capture and recording
  • Event transmission and near time recording in one device
  • Patient activated event recording feature

4 Simple Steps

for quicker diagnosis

Step 1

Zensor™ device assigned, placed on patient and activated

"very useful for quick diagnosis"

Step 2

Data transmits to Zensor™ device monitoring centre where data is captured

"Easy to use for clinical staff and patients"

Step 3

After 14 days (or earlier if Clinician chooses) patient returns device for processing

"I felt confident using the Zensor ™ device"

Step 4

Report sent back to Clinician to support diagnosis

About

the company

“To discover, develop & commercialise pioneering technologies and solutions to make lives better in an ever changing world.”